2.51
-0.1599(-5.99%)
Currency In USD
| Previous Close | 2.67 |
| Open | 2.57 |
| Day High | 2.59 |
| Day Low | 2.51 |
| 52-Week High | 15.7 |
| 52-Week Low | 1.72 |
| Volume | 42,305 |
| Average Volume | 3.25M |
| Market Cap | 5.03M |
| PE | -0.22 |
| EPS | -11.65 |
| Moving Average 50 Days | 2.84 |
| Moving Average 200 Days | 3.56 |
| Change | -0.16 |
If you invested $1000 in InMed Pharmaceuticals Inc. (INM) 10 years ago, it would be worth $1.27 as of July 30, 2025 at a share price of $2.51. Whereas If you bought $1000 worth of InMed Pharmaceuticals Inc. (INM) shares 5 years ago, it would be worth $1.31 as of July 30, 2025 at a share price of $2.51.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
InMed to Present INM-901 Data at Alzheimer's Association International Conference (AAIC) 2025
Newsfile
Jul 28, 2025 11:00 AM GMT
Long-term INM-901 treatment in preclinical studies in advanced disease continues to show multi-modal activityVancouver, British Columbia--(Newsfile Corp. - July 28, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharma
InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules
Newsfile
Jun 27, 2025 11:00 AM GMT
Vancouver, British Columbia--(Newsfile Corp. - June 27, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases
InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Newsfile
Jun 25, 2025 12:00 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases